Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MetriGenix was a life sciences tools company that developed and commercialized the 4D Array System, a proprietary flow-through microarray technology. Unlike traditional flat-surface microarrays, the 4D Array utilized a three-dimensional microfluidic chip to enhance the speed and sensitivity of genomic and proteomic analysis. The company's products were designed for gene expression profiling, SNP genotyping, and diagnostic applications. MetriGenix was headquartered in Gaithersburg, Maryland, and served the pharmaceutical and academic research markets. In 2004, the company's assets were acquired by Pall Corporation to bolster its molecular diagnostics and laboratory business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MetriGenix.